Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease

Movement Disorders

Volumn 24, Issue 12, 2009, Pages 1864-1866

  Galvez, Marcelo ^a   Brahm, Javier ^a   Miranda, Marcelo ^a  

^a CLÍNICA LAS CONDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; METRONIDAZOLE; SPIRONOLACTONE; VITAMIN K GROUP;

ADULT; ATAXIA; BRAIN DAMAGE; BRAIN DISEASE; CASE REPORT; CHOREA; CHRONIC LIVER DISEASE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSARTHRIA; HEPATIC ENCEPHALOPATHY; HEPATITIS C VIRUS; HUMAN; INTERACTIONS WITH NUCLEIC ACID; IRON OVERLOAD; LETTER; MALE; MOTOR DYSFUNCTION; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PORPHYRIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTI-INFECTIVE AGENTS; BRAIN DISEASES; CHRONIC DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LIVER DISEASES; MALE; METRONIDAZOLE; MIDDLE AGED; MOVEMENT DISORDERS;

EID: 70449895337     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22624     Document Type: Letter

References (4)

1. Freeman CD, Klutman N, Lamp K. Metronidazole a therapeutic review and update. Drugs 1995;54:679-708.
2. Kim E, Na D, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of Metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR 2007;28:1652-1658.
3. Aemed A, Loes D, Bressler E. Reversible resonance imaging findings in metronidazole-induced encephalopathy. Neurology 1995;45:588-589.
4. Woodriff BK, Wijdicks EF, Marshall WF. Reversible metronidazole- induced lesions of the cerebellar dentate nuclei. N Engl J Med 2002;346:68-69.